SHC — Sotera Health Co Income Statement
0.000.00%
Last trade - 00:00
- $4.23bn
- $6.30bn
- $1.05bn
- 91
- 18
- 76
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 778 | 818 | 931 | 1,004 | 1,049 |
Cost of Revenue | |||||
Gross Profit | 395 | 444 | 519 | 557 | 577 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 625 | 656 | 695 | 1,173 | 808 |
Operating Profit | 153 | 162 | 236 | -169 | 242 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.916 | -38.9 | 176 | -243 | 106 |
Provision for Income Taxes | |||||
Net Income After Taxes | -20.4 | -37.5 | 117 | -234 | 51.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -20.9 | -38.6 | 117 | -234 | 51.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -20.9 | -38.6 | 115 | -234 | 51.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.009 | 0.082 | 0.566 | 0.324 | 0.377 |
Dividends per Share |